Pathobot is an AI-powered digital pathology platform designed to revolutionize disease diagnostics by addressing critical gaps in accuracy, speed, and accessibility. Traditional pathology, often dependent on manual analysis and a limited pool of skilled pathologists, especially in rural areas, is prone to delays and errors. Pathobot leverages artificial intelligence to automate the analysis of pathology slides, enabling faster, consistent, and more reliable diagnosis for conditions such as cancer, infections, and chronic diseases. The platform serves both diagnostic labs and individual users. For labs and hospitals, Pathobot offers scalable diagnostic solutions that improve operational efficiency, reduce turnaround time, and support remote analysis. For users, the app provides easy access to medical test results, personalized health insights, and teleconsultation support. Additional features like real-time tracking, health calculators, and a rewards system enhance user engagement. Revenue is generated through a subscription model for advanced features, lab partnerships for referral fees, in-app ads, affiliate marketing, and anonymized data insights offered to research institutions. Pathobot’s scalable, cloud-based architecture ensures data security and seamless integration with existing lab infrastructure. By combining AI, healthcare data, and user-focused tools, Pathobot aims to democratize diagnostic services, improving healthcare outcomes across urban and underserved regions alike.
Show MoreYear of Establishment2023